My Size, Inc. 8-K

What Happened
My Size, Inc. announced on December 15, 2025 (filed in an 8-K under Item 5.02) that its Compensation Committee approved restricted stock awards to executive officers under the Company’s 2017 Equity Incentive Plan. Awards include performance-based shares that vest upon achievement of specified profit and business targets and time-based shares that vest in three equal annual installments on Jan 1, 2026, 2027 and 2028, subject to continued service.

Key Details

• Grants approved: Dec 15, 2025; awarded under the Company’s 2017 Equity Incentive Plan and the Form of Section 102 Capital Gain Restricted Stock Award Agreement (previously filed).
• CEO Ronen Luzon: 125,000 performance-based shares and 75,000 time-based shares.
• Chief Growth Officer Cembrero Saralegui Borja: 60,000 performance-based and 50,000 time-based (10,000 of the time-based shares are fully vested on grant).
• Chief Product & Operating Officer Billy Pardo: 20,000 performance-based and 40,000 time-based.
• CFO Oren Elmaliah: 0 performance-based and 30,000 time-based.
• Vesting: Performance awards vest upon meeting specified profit/business targets; time awards vest in three equal annual installments (Jan 1, 2026–2028), subject to continued service.

Why It Matters
These grants are executive compensation actions that align pay with performance and retention: performance-based awards tie pay to specific profit/business targets, while time-based awards encourage executives to remain with the company through 2028. For investors, such awards can increase share-based compensation expense and may dilute existing shareholders if and when restricted shares vest and are issued. The full terms are governed by the Company’s previously filed restricted stock award agreement.